Clinical Trial Update: Contribution From PET-DOPA in Glioblastoma Re-irradiation - A Randomized Phase II Study [Phase 2]

View source ↗

Summary

A randomized Phase II trial is evaluating the use of PET-DOPA imaging to guide re-irradiation in patients with glioblastoma and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• 18F-DOPA (fluorodopa) PET tracer (fluorodopa)

Snippet

Sponsor: Centre Paul Strauss | Conditions: Glioblastoma | Phase 2 | Status: RECRUITING